Qian H - Search Results

1

The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.

Wang Y, Appiah-Kubi K, Wu M, Yao X, Qian H, Wu Y, Chen Y. Wang Y, et al. Among authors: qian h. Growth Factors. 2016 Feb;34(1-2):64-71. doi: 10.1080/08977194.2016.1180293. Epub 2016 May 12. Growth Factors. 2016. PMID: 27170215 Review.

2

Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.

Appiah-Kubi K, Wang Y, Qian H, Wu M, Yao X, Wu Y, Chen Y. Appiah-Kubi K, et al. Among authors: qian h. Tumour Biol. 2016 Aug;37(8):10053-66. doi: 10.1007/s13277-016-5069-z. Epub 2016 May 19. Tumour Biol. 2016. PMID: 27193823 Review.

3

Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies.

Appiah-Kubi K, Lan T, Wang Y, Qian H, Wu M, Yao X, Wu Y, Chen Y. Appiah-Kubi K, et al. Among authors: qian h. Crit Rev Oncol Hematol. 2017 Jan;109:20-34. doi: 10.1016/j.critrevonc.2016.11.008. Epub 2016 Nov 21. Crit Rev Oncol Hematol. 2017. PMID: 28010895 Review.

4

The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.

Qian H, Appiah-Kubi K, Wang Y, Wu M, Tao Y, Wu Y, Chen Y. Qian H, et al. Crit Rev Oncol Hematol. 2018 Jul;127:15-28. doi: 10.1016/j.critrevonc.2018.05.004. Epub 2018 May 16. Crit Rev Oncol Hematol. 2018. PMID: 29891108 Review.

5

Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.

Jiang L, Chen Y, Li Y, Lan T, Wu M, Wang Y, Qian H. Jiang L, et al. Among authors: qian h. Mol Med Rep. 2014 Apr;9(4):1405-9. doi: 10.3892/mmr.2014.1942. Epub 2014 Feb 10. Mol Med Rep. 2014. PMID: 24534906

6

Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells.

Zhu M, Yao X, Wu M, Qian H, Wu Y, Chen Y. Zhu M, et al. Among authors: qian h. Mol Med Rep. 2016 Feb;13(2):1909-13. doi: 10.3892/mmr.2015.4688. Epub 2015 Dec 17. Mol Med Rep. 2016. PMID: 26676300

7

PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.

Wu Y, Yao X, Zhu M, Qian H, Jiang L, Lan T, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: qian h. Oncotarget. 2016 Jun 7;7(23):34190-200. doi: 10.18632/oncotarget.9074. Oncotarget. 2016. PMID: 27147579 Free PMC article.

8

Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.

Wu M, Wu Y, Lan T, Jiang L, Qian H, Chen Y. Wu M, et al. Among authors: qian h. Mol Med Rep. 2016 Aug;14(2):1849-56. doi: 10.3892/mmr.2016.5452. Epub 2016 Jun 27. Mol Med Rep. 2016. PMID: 27357186

9

Cross-linked hyaluronic acid gel inhibits metastasis and growth of gastric and hepatic cancer cells: in vitro and in vivo studies.

Lan T, Pang J, Wu Y, Zhu M, Yao X, Wu M, Qian H, Zhang Z, Gao J, Chen Y. Lan T, et al. Among authors: qian h. Oncotarget. 2016 Oct 4;7(40):65418-65428. doi: 10.18632/oncotarget.11739. Oncotarget. 2016. PMID: 27589842 Free PMC article.

10

PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.

Qian H, Tao Y, Jiang L, Wang Y, Lan T, Wu M, Pang J, Appiah-Kubi K, Chen Y, Wu Y. Qian H, et al. Cell Biol Int. 2018 Apr;42(4):435-442. doi: 10.1002/cbin.10912. Epub 2017 Dec 14. Cell Biol Int. 2018. PMID: 29150923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,153 results

Search Page

Filters